Key result
Presence of a 19p+ marker chromosome in malignant fibrous histiocytomas was associated with an increased rate of distant metastases and/or local recurrence (88.9% vs 30.8%).
Why the study?
Does the presence of a 19p+ marker chromosome predict relapse in patients with malignant fibrous histiocytomas?
Cohort (n=22)
Does the presence of a 19p+ marker chromosome predict relapse in patients with malignant fibrous histiocytomas?
The presence of a 19p+ marker chromosome in malignant fibrous histiocytomas is associated with an increased risk of relapse, whereas ring markers may indicate a reduced risk.
19p+ may identify higher-relapse-risk malignant fibrous histiocytomas; hypothesis-generating and should not yet change practice.
Malignant fibrous histiocytomas (MFH) often have complex karyotypic abnormalities. Recently, we described a 19p+ marker chromosome in 9 of 22 MFH. Other recurrent karyotypic features have been telomeric associations, ring chromosomes, and structural rearrangements of chromosomal bands 1q11, 3p12, and 11p11. After a median follow-up time of 18 months, distant metastases and/or local recurrence have occurred in 8 of the 9 patients with 19p+ markers but in only 4 of the 13 patients without. The only other cytogenetic parameter that seemed to affect relapse tendency was the presence of ring markers: relapse has occurred in 2 of 8 patients with unidentifiable supernumerary ring marker chromosomes compared to 10 of 14 patients without. No differences in relapse frequency were apparent for tumors belonging to the other cytogenetic subgroups. It thus appears that 19p+ marker chromosomes in MFH signal an increased relapse risk whereas the finding of ring markers indicates a reduced relapse risk.
No takes yet. Share an insight, caveat, or question.
Rydholm et al. (1990) conducted a cohort in Malignant fibrous histiocytomas (n=22). 19p+ marker chromosome vs. Absence of 19p+ marker chromosome was evaluated on Distant metastases and/or local recurrence. Presence of a 19p+ marker chromosome in malignant fibrous histiocytomas was associated with an increased rate of distant metastases and/or local recurrence (88.9% vs 30.8%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: